Wondering what comes next after a clinical trial? This page explains how you might keep taking the medicine, when results are shared, and how approval works.
Can patients continue getting the medicine after a clinical trial is complete?
Maybe. Some clinical trials offer an open-label extension (OLE) after the main part of the study is done. This means everyone in the trial—even those who got a placebo—can choose to take the real medicine.
Open-label extensions are optional. If you decide to join, the study team will still collect information about your health while you take the medicine. This helps researchers learn even more about how the medicine works over a longer period.
Will I learn about the results of the clinical trial?
Yes, you will get to learn about the overall results of the trial, but you won’t usually get your personal test scores. It may take a while—sometimes 6 to 18 months—after you finish your part in the trial. That’s because all participants must finish before the study team can look at the full set of data.
Once the results are ready, the study team may share them in a newsletter, on social media, or in a press release. The FSHD Society may also hold a webinar to explain the results to the community. Study teams usually publish results in science journals or present them at conferences too. Keep an eye out for updates!
Explore the Latest Updates